CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV

BACKGROUND: Chemokines/cytokines play important roles in the pathogenesis of chronic hepatitis C (CHC). However, their clinical characteristics and implications in treatment responses to pegylated interferon plus ribavirin treatment (PegIFN/RBV) have not been fully illustrated yet. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chia-Chen, Su, Shih-Huan, Jeng, Wen-Juei, Huang, Chien-Hao, Teng, Wei, Chen, Wei-Ting, Chen, Yi-Cheng, Lin, Chun-Yen, Sheen, I-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747242/
https://www.ncbi.nlm.nih.gov/pubmed/29284412
http://dx.doi.org/10.1186/s12876-017-0724-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747242/
https://www.ncbi.nlm.nih.gov/pubmed/29284412
http://dx.doi.org/10.1186/s12876-017-0724-4

Ejemplares similares